Plain Packaging Action Alert - NEW ZEALAND
In February, Associate Health Minister Tariana Turia announced the Government will introduce legislation on plain tobacco packaging after reviewing submissions made during the public consultation.
It is expected that New Zealand will have its first plain packs by next year, subject to the outcome of international legal challenges currently faced by the Australia Government. The prospect of plain packaging of tobacco products in New Zealand is positive, given that the effectiveness of plain packaging has been proven (by research) to remove the persuasive power of the current attractive imagery and hence the attractiveness of tobacco products. The new plain packs convey a strong message that tobacco products kill half of its users, when used exactly as intended.
The New Zealand regime will be similar to that of Australia – all tobacco products will be sold in dark olive coloured packages with generic font. This format is regarded as the least attractive and perceived as least visually appealing and was developed after rigorous marketing testing.
Until now, evidence is strongly in favour of plain packs, especially after the world-first plain pack introduction in Australia.
A new Australian study, based on real world shopping experiences, shows that plain packs do not inconvenience retailers or customers. 1 The study included a sample of 303 various kinds of retail outlets in four capital cities, stratified by socioeconomic status. The study shows that following the introduction of plain packs, the average retail transaction time increased by two to three seconds, to around 12.5 seconds, but quickly returns to normal and was recorded at 10.37 seconds in February. This is contrary to claims made by the tobacco industry and their front groups at the time of plain pack introduction in Australia that plain packs would significantly impact on transaction times in shops due to long delays, queues, and confusion.
Another simulation study in Australia has also demonstrated that plain packs modestly decreased selection errors and reduced transactions time.2
Both studies also suggested that retailers would quickly accustom to retrieve the plain packs.
Ireland has proclaimed their intention to introduce plain pack and Scotland is committed regardless of the delay in the UK.
As a party to the WHO’s treaty (Framework Convention on Tobacco Control), New Zealand has an obligation to put public health as a priority. The WHO also requires party to
Guidelines on Article 11 of the treaty also recommend that treaty partners introduce plain packaging.
Plain tobacco packaging is one of the most effective ways to prevent our children from taking up smoking. The prospect of the introduction of plain packaging for tobacco products in New Zealand is positive and we will continue to keep you informed on the progress.
· Scotland committed to plain cigarette pack plan http://www.scotsman.com/news/health/scotland-committed-to-plain-cigarette-pack-plan-1-2999503
· Ireland plans to adopt plain packaging of cigarettes
Two recent Australian studies estimated the transaction time of retail stores after plain packs were introduced. We have summarised the key points in the attached factsheet.
- Carter OBJ, Mills BW, Phan T, Bremner JR. Measuring the effect of cigarette plain packaging on transaction times and selection errors in a simulation experiment 10.1136/tobaccocontrol-2011-050087 Tobacco Control 2011
- Wakefield M, Bayly M, Scollo M. Product retrieval time in small tobacco retail outlets before and after the Australian plain packaging policy: real-world study 10.1136/tobaccocontrol-2013-050987 Tobacco Control 2013
ANZSRS, Spirometry Training Consultation Paper
The ANZSRS has just released its consultation paper on spirometry training. - PLEASE CLICK HERE
The National Asthma Council Australia has been asked to help advise stakeholders of the following consultation by the Australian and New Zealand Society of Respiratory Science (ANZSRS). The ANZSRS plans to introduce a new standardised program for training in spirometry testing. Successful completion of the program will give the participant the ANZSRS Spirometry Driving License (ANZSRS SDL), a new method of spirometry certification based on the European Respiratory Society system.
As part of the consultation process, ANZSRS seeks some feedback from stakeholders involved in the management and treatment of respiratory diseases on this proposed program.
Please read the attached ANZSRS Consultation Paper and click HERE to complete the short survey. Please provide your feedback by 30 September 2013
Obtaining TSANZ Support and Endorsement of Education and Training Courses, Materials and Resources
Disease Exercise ILD Study
We would like to inform you of a research trial we are currently conducting at the Alfred, Austin, Western and Sunshine Hospital called "Defining the benefits of exercise training in interstitial lung disease: a multi-centre randomised controlled trial".
For further information - PLEASE CLICK HERE
For participant flier - PLEASE CLICK HERE
The primary aim of this project is to establish the role and impact of exercise training in ILD on interstitial lung diseases (ILDs) of different aetiology and severity and to identify whether there is an optimal time for patients to receive exercise training to achieve maximal benefit. Participants will be randomised to 8 weeks of exercise training or a control group (usual care). Each participant will complete an assessment at baseline, post intervention and at 6 months follow up. Those participants that were randomised to the control group will be offered pulmonary rehabilitation at their 6 month follow up assessment.
We would be extremely grateful if you would refer any patients you treat that have IPF, Dust related or Connective related ILD that you feel may be suitable for this trial. If you have any queries or referrals, please contact:
Exercise ILD Coordinator (all sites)
c/o Physiotherapy Department
Austin Hospital, Po Box 5555, Heidelberg 3084
0423 614 218
ARNOLD - Australian Registry Network for Orphan Lung Disease
For more information please read the flyer here.
Also go to the ARNOLD website at www.arnold.org.au
This is a joint initiative of the Australian Lung Foundation and the Thoracic Society of Australia and New Zealand Ltd.
Australian Idiopathic Pulmonary Fibrosis (IPF) Registry
Australian Idiopathic Pulmonary Fibrosis Registry is now established and is recruiting participants.
Registry Coordinators in each State will facilitate participant consent and the data collection process.
Eligible participants are those patients with a clinical diagnosis of IPF and who are able to complete a 30-minute questionnaire. A surgical biopsy is not necessary for referral.
To locate the Registry Coordinator in your State please contact Australian IPF Registry Project Manager, Sacha Macansh telephone 02 9515 3996 or by email email@example.com.
AUS IPF-net newsletter
Read the inaugural edition of the Registry AUS IPF-net newsletter. Featured is the IPF research presented at ATS 2012. Registry Coordinators are now working in most States; see the AUS IPF-net newsletter for their details.
Join AUS IPF-net to continue receiving this publication, please email firstname.lastname@example.org
AUS IPF-net is the special interest group of the Autralian IPF Registry; it's open to all health care professionals. For more information please contact the Australian IPF Registry Project Manager, Sacha Macansh by telephone (02) 9515 3996 or by email email@example.com